Epilepsy surgery for children and adolescents: evidence-based but underused

J Helen Cross1, Colin Reilly2, Eva Gutierrez Delicado3

  • 1Developmental Neurosciences Programme, Great Ormond Street Institute of Child Health, University College London, London, UK; Department of Neurology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK; Research Department, Young Epilepsy, Lingfield, UK.

Insights

Pediatric epilepsy surgery is a safe and effective treatment. Early surgical intervention in children with epilepsy can significantly improve seizure control and overall quality of life.

Area of Science:

  • Neurology
  • Pediatric Surgery
  • Epileptology

Background:

  • Paediatric epilepsy surgery is an established, evidence-based treatment with a low complication rate.
  • Advances in neuroimaging and diagnostics have expanded eligibility for pediatric epilepsy surgery.
  • Surgery is a standard management approach for epilepsy in children, with early intervention linked to better outcomes.

Purpose of the Study:

  • To review current indications and patient selection for pediatric epilepsy surgery.
  • To outline presurgical investigation principles and optimal surgical timing.
  • To examine comprehensive outcomes following pediatric epilepsy surgery.

Main Methods:

  • Review of current literature on pediatric epilepsy surgery.
  • Analysis of indications, patient selection criteria, and diagnostic methods.
  • Evaluation of surgical outcomes, including seizure control, neurodevelopment, and quality of life.

Main Results:

  • Pediatric epilepsy surgery is underutilized despite its benefits.
  • Early surgical intervention is associated with improved outcomes.
  • Successful surgery can enhance seizure control, cognition, neurodevelopment, and quality of life for children and their families.

Conclusions:

  • Children with epilepsy should be referred for surgical evaluation early.
  • Referral to a specialized pediatric epilepsy surgery center is recommended.
  • Timely surgical intervention offers significant benefits for children with refractory epilepsy.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
302
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
212
Psychosurgery01:30

Psychosurgery

Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
120
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
472
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
629